Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
Mastronardi Produce long-term leases
We advised Mastronardi Produce on the transaction
AUO €600 million acquisition of BHTC
We are advising AUO on the acquisition
NICE acquisition of LiveVox
We are advising NICE on the acquisition
TPG financing for Forcepoint G2CI acquisition
We advised TPG on the credit facilities
Delta, Certares, Knighthead and Cox investment in Wheels Up
We advised the investors on the financing and acquisition of 95% of the equity of Wheels Up
Comcast sale of spectrum to T-mobile
We are advising Comcast on the transaction
Summit Materials $3.2 billion combination with Argos USA
We are advising Summit Materials on the transaction
Orogen Group investment in Brillio
We advised the Orogen Group on the investment
PracticeTek merger with Integrated Practice Solutions and related financing
We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider